Aripiprazole: a novel atypical antipsychotic acts as stabilizer of the dopamine system

被引：0
|
作者：
Klein, N [1 ]
Wallner, H [1 ]
Kasper, S [1 ]
机构：
[1] Klin Abt Allgemeine Psychiat, A-1090 Vienna, Austria
来源：
PSYCHOPHARMAKOTHERAPIE | 2006年 / 13卷 / 02期
关键词：
aripiprazole; dopamine stabilizer; partial agonist; schizophrenia; bipolar disorder;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Aripiprazole is a new atypical antipsychotic with a unique mechanism of action. It is a partial agonist to the D-2 receptor and therefore acts as stabilizer of the dopaminergic system. Aripiprazole has been shown to have good efficacy on (a) treating positive and negative symptoms of schizophrenia and (b) treating bipolar disorders. Furthermore, aripiprazole has a favourable adverse event profile, which in many cases does not differ from placebo.
引用
收藏
页码：49 / +
页数：6
相关论文
共 50 条
  • [41] Aripiprazole, an atypical antipsychotic prevents the motor hyperactivity induced by psychotomimetics, and psyphostimulants in mice
    Leite, Juliana V.
    Guimaraes, Francisco S.
    Moreira, Fabricio A.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2008, 578 (2-3) : 222 - 227
  • [42] Aripiprazole an atypical antipsychotic protects against ethanol induced gastric ulcers in rats
    Al Asmari, Abdulrahman
    Arshaduddin, Mohammed
    Elfaki, Ibrahim
    Kadasah, Saeed
    Al Robayan, Abdulrahman
    Al Asmary, Saeed
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2014, 7 (08): : 2031 - 2044
  • [43] Add-on aripiprazole for atypical antipsychotic-induced, clinically significant hyperprolactinemia
    Raveendranthan, Dhanya
    Rao, Naren P.
    Rao, Mukund G.
    Mangot, Ajish G.
    Varambally, Shivaram
    Kesavan, Muralidharan
    Venkatasubramanian, Ganesan
    Gangadhar, Bangalore N.
    INDIAN JOURNAL OF PSYCHOLOGICAL MEDICINE, 2018, 40 (01) : 38 - 40
  • [44] Anti-aversive effects of the atypical antipsychotic, aripiprazole, in animal models of anxiety
    Biojone, Caroline
    Casarotto, Plinio C.
    Resstel, Leonardo B.
    Zangrossi, Helio, Jr.
    Guimaraes, Francisco S.
    Moreira, Fabricio A.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2011, 25 (06) : 801 - 807
  • [45] Acute and long-term efficacy and safety of aripiprazole: A new atypical antipsychotic
    Petrie, JL
    Saha, AR
    McEvoy, JP
    SCHIZOPHRENIA RESEARCH, 1998, 29 (1-2) : 155 - 155
  • [46] The pharmacology and mechanisms of action of atypical antipsychotic drugs: dopamine and beyond
    David Sanger
    Annals of General Psychiatry, 5 (Suppl 1)
  • [47] Effects on serotonin and dopamine receptors in the mechanism of atypical antipsychotic drugs
    Meltzer, HY
    Kessler, R
    Li, Z
    Chung, Y
    Ichikawa, J
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S164 - S165
  • [48] SEROTONIN-DOPAMINE INTERACTIONS AND ATYPICAL ANTIPSYCHOTIC-DRUGS
    MELTZER, HY
    PSYCHIATRIC ANNALS, 1993, 23 (04) : 193 - 200
  • [49] Body weight changes in patients with acute mania treated with combination of mood stabilizer and atypical antipsychotic or typical antipsychotic
    Kang, M. H.
    Jeon, J. S.
    Kim, C. E.
    Lee, J. S.
    Bae, J. N.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S350 - S351
  • [50] Aripiprazole acts as a selective dopamine D2 receptor partial agonist
    Wood, Martyn
    Reavill, Charlie
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (06) : 771 - 775
12345